Oncology & Cancer

Researchers find new treatment for prostate cancer

Professor Fahri Saatcioglu at University of Oslo's Department of Biosciences (IBV) heads a research group investigating how androgens – male sex hormones – affect the risk of being affected by prostate cancer. The researchers ...

Oncology & Cancer

Finasteride does not increase risk of prostate cancer death

Twenty five years after it opened for enrollment, the landmark Prostate Cancer Prevention Trial has delivered a final verdict. Finasteride, a common hormone-blocking drug, reduces mens' risk of getting prostate cancer without ...

Oncology & Cancer

Breakthrough discovery to transform prostate cancer treatment

A novel formulation of the prostate cancer drug abiraterone acetate—currently marketed as Zytiga—will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University ...

Oncology & Cancer

Testosterone slows prostate cancer recurrence in low-risk patients

In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk patients. This may call into question the general applicability of Nobel-Prize ...

page 2 from 40